ZOPHREN 4 mg, lyophilizate oral 4 oral lyophilisates
Active ingredients: Ondansetron
Commercialized according to BDPMDispensing in France: Prescription only
Lyophilizate4 oral lyophilisatesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZOPHREN 4 mg, lyophilisat oral
- Pharmaceutical form
- lyophilisat
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 4 lyophilisat(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61187301CIP73439452CIP133400934394522Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ONDANSÉTRONlyophilisat | 4,0000 mg · un lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.